Alzheimer's

November 11, 2024

A new drug promises to curb multiple sclerosis, Parkinson's and Alzheimer's

Researchers at University College London and Loyola University have developed a modified compound of cyclosporin A that blocks cyclophilin D in the brain, offering a new avenue for treating neurodegenerative diseases. Early animal studies show promising results.